Design of allosteric modulators that change GPCR G protein subtype selectivity
Preprint
- 11 December 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
G protein-coupled receptors (GPCRs), the largest family of drug targets, can signal through 16 subtypes of Gα proteins. Biased compounds that selectively activate therapy-relevant pathways promise to be safer, more effective medications. The determinants of bias are poorly understood, however, and rationally-designed, G protein-subtype-selective compounds are lacking. Here, using the prototypical class A GPCR neurotensin receptor 1 (NTSR1), we find that small molecules binding the intracellular GPCR-transducer interface change G protein coupling by subtype-specific and predictable mechanisms, enabling rational drug design. We demonstrate that the compound SBI-553 switches NTSR1 G protein preference by acting both as a molecular bumper and a molecular glue. Structurally, SBI-553 occludes G protein binding determinants on NTSR1, promoting association with select G protein subtypes for which an alternative, shallow-binding conformation is energetically favorable. Minor modifications to the SBI-553 scaffold produce allosteric modulators with distinct G protein subtype selectivity profiles. Selectivity profiles are probe-independent, conserved across species, and translate to differences in in vivo activity. These studies demonstrate that G protein selectivity can be tailored with small changes to a single chemical scaffold targeting the receptor-transducer interface and, as this pocket is broadly conserved, present a strategy for pathway-selective drug discovery applicable to the diverse GPCR superfamily.Keywords
All Related Versions
- Version 1, 2024-12-11, Research Square
- Published version: Nature, 648 (8092), 229.
This publication has 46 references indexed in Scilit:
- Biased allosteric modulator of neurotensin receptor 1 reduces ethanol drinking and responses to ethanol administration in rodentsAddiction Neuroscience, 2024
- Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discoveryDrug Discovery Today, 2023
- Rules and mechanisms governing G protein coupling selectivity of GPCRsCell Reports, 2023
- β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsCell, 2020
- Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7Cell, 2019
- PD149163 induces hypothermia to protect against brain injury in acute cerebral ischemic ratsJournal of Pharmacological Sciences, 2017
- Activation of neurotensin receptor type 1 attenuates locomotor activityNeuropharmacology, 2014
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Reduced amide bond neurotensin 8–13 mimetics with potent in vivo activityBioorganic & Medicinal Chemistry Letters, 1995
- Hypothermia elicited by the intracerebral microinjection of neurotensinPeptides, 1980